UCB Biopharma SRL
1,395.2 FTEUCB Biopharma reported revenue of €2.04bn for the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026), with 1,395.2 full-time equivalents.
By total assets for 2025, UCB Biopharma ranks among the 5 largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of UCB Biopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -28 % Equity +21 % Total assets +35 % Headcount (avg FTE) +10 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
UCB Biopharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €2.04bn | ||||
| Net result | €113.8m | ||||
| Equity | €1.18bn | ||||
| Cash | €153.8m | ||||
| EBITDA | €1.81bn | ||||
| Total assets | €7.15bn |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 21 Jul 2023
- Year ended 31 Dec 2021filed on 18 Jul 2022
UCB Biopharma's financial analysis
- Solvency16.4%sector median: 41.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of UCB Biopharma
UCB Biopharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0543.573.053
- VAT number
- BE0543573053
- Peppol
- Registered · 0208:0543573053 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Dec 2013
- Registered office
- 1070 Anderlecht
- Size
- Large · 1,395.2 FTE
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
UCB Biopharma (SRL) has been based in Anderlecht since 2013, active in: manufacture of medicaments. For 2025, it reports revenue of €2.04bn, a net profit of €113.8m and equity of €1.18bn. With 1,395.2 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 16.4%, below the median of its sector (41.4%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to UCB Biopharma
Companies in the same business, of comparable size and area, outside its group.
- argenx Research and experimental development on natural sciences and engineering Ghent · balance sheet €7.01bn
- Lakefront Biotherapeutics Research and experimental development on natural sciences and engineering Mechelen · balance sheet €3.34bn
- Genzyme Flanders Manufacture of pharmaceutical preparations Geel · balance sheet €1.00bn
- UCB Developed Brands Research and experimental development on natural sciences and engineering Anderlecht · balance sheet €1.07bn
- Telix Innovations Manufacture of basic pharmaceutical products Herstal · balance sheet €473.4m
- Laboratoires S.M.B. Manufacture of pharmaceutical preparations Molenbeek-Saint-Jean · balance sheet €261.5m
- Pfizer Manufacture of pharmaceutical preparations Ixelles · balance sheet €377.4m
- Omega Pharma Innovation & Development Research and experimental development on natural sciences and engineering Ghent · balance sheet €246.6m
Frequently asked questions about UCB Biopharma
What is the revenue of UCB Biopharma?
According to the 2025 annual accounts filed with the NBB, the revenue of UCB Biopharma amounts to 2,040,772,677 €.
What is the VAT number of UCB Biopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0543573053 for UCB Biopharma, if the company is VAT-registered. Its company number (CBE) is 0543.573.053.
Where is the registered office of UCB Biopharma?
According to the CBE register, the registered office of UCB Biopharma is in 1070 Anderlecht.
What is the equity of UCB Biopharma?
At the close of the 2025 financial year, the equity of UCB Biopharma amounts to 1,175,020,354 €, a solvency of 16.4% of total assets.
How many people work at UCB Biopharma?
1,395.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages UCB Biopharma?
The register lists 4 active mandates at UCB Biopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is UCB Biopharma within its sector?
By total assets for 2025, UCB Biopharma ranks among the 5 largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year.
The full file of UCB Biopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →